VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 3 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2021. The put-call ratio across all filers is - and the average weighting 2.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | – | 0 | – | 0.00% | – |
Q4 2020 | $0 | – | 0 | – | 0.00% | – |
Q3 2020 | $0 | – | 0 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q2 2018 | $688,000 | +42.1% | 29,618 | +27.2% | 0.03% | +31.8% |
Q1 2018 | $484,000 | 0.0% | 23,277 | 0.0% | 0.02% | 0.0% |
Q4 2017 | $484,000 | -73.6% | 23,277 | -81.8% | 0.02% | -69.9% |
Q3 2017 | $1,836,000 | -17.3% | 128,095 | -0.2% | 0.07% | -22.3% |
Q2 2017 | $2,220,000 | +57.4% | 128,305 | +0.4% | 0.09% | +54.1% |
Q1 2017 | $1,410,000 | -16.0% | 127,796 | +10.6% | 0.06% | -24.7% |
Q4 2016 | $1,678,000 | -60.6% | 115,556 | -33.4% | 0.08% | -63.5% |
Q3 2016 | $4,262,000 | +22.9% | 173,588 | +0.8% | 0.22% | +14.4% |
Q2 2016 | $3,467,000 | -77.6% | 172,134 | +12.8% | 0.19% | -81.4% |
Q4 2015 | $15,509,000 | – | 152,572 | – | 1.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |